You are here: Home News and Events 2010 Louisville Breast Cancer Update

2010 Louisville Breast Cancer Update

by Goff,Phillip Craig last modified Oct 22, 2010 01:13 PM
— filed under:

What
  • Seminar
When Oct 23, 2010
from 07:00 am to 12:30 pm
Where Jewish Hospital Rudd Heart & Lung Bldg. 201 Abraham Flexner Way, #903 Louisville, KY 40202
Add event to calendar vCal
iCal

   *Agenda   *Brochure   *CE Credit   *Course Director & Faculty   *Registration

Course Description and Target Audience
This multidisciplinary symposium will allow participants to gain greater insight into the latest advances in breast cancer research and treatment. Basic scientists and clinicians involved in all aspects of breast cancer care will have an opportunity to interact and gain a greater mutual understanding resulting in improved care for patients.

The target audience consists of health professionals who treat breast cancer.  This includes nurses, general internists, family physicians, radiologists, pathologists, general surgeons, surgical oncologists, plastic surgeons, medical oncologists, radiation oncologists, genetic counselors and allied health professionals.  In addition, the symposium attracts basic scientists interested in breast cancer research.


adbreastcancer10.jpgAgenda
7:00 am
Registration/Continental Breakfast

7:30 am
Welcome
Anees B. Chagpar, M.D.

7:45 am
Should routine screening mammography start at age 40?
Barbara  A. Pockaj, M.D.

8:30 am
Should all node positive patients undergo an axillary node dissection?
Anees Chagpar, M.D.

9:15 am
Should patients who are potential candidates for radiation therapy have immediate reconstruction?
Jarrod A. Little, M.D.

10:00 am
Break

10:15 am
Should ABPI be standard of care?
Anthony Dragun, M.D.

11:00 am
Should all ER+ breast cancer patients (including DCIS) receive hormonal therapy?
Clifford Hudis, M.D.

11:45 am
Tumor Board
All faculty; moderated by Anees Chagpar, M.D

12:30 pm
Evaluations/Adjourn


Course Director
Anees B. Chagpar, M.D.
Associate Professor
Division of Surgical Oncology
University of Louisville School of Medicine
Louisville, KY

Faculty
Anthony E. Dragun, M.D.
Assistant Professor
Radiation Oncology
James Graham Brown Cancer Center
Louisville, KY

Clifford Hudis, M.D.
Chief, Breast Cancer Medicine Service
Memorial Sloan-Kettering Cancer Center
New York, NY

Jarrod A. Little, M.D.
Assistant Professor
Department of Surgery, Division of Plastic Surgery
University of Louisville School of Medicine
Louisville, KY

Barbara A. Pockaj, M.D.
Professor of Surgery
Breast Clinic, Mayo Clinic Hospital
Phoenix, AZ


Continuing Education Credit
Physician Credit
- The University of Louisville Continuing Health Sciences Education office designates this educational activity for a maximum of 4.5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Nursing Credit - This program has been approved by the Kentucky Board of Nursing for 5.4 contact hours through the University of Louisville School of Nursing, provider number 3-0046-01-2013-145, expiration date January 31, 2013. The Kentucky Board of Nursing approval of an individual nursing education provider does not constitute endorsement of program content. Participants must complete entire session, provide license and social security number and complete evaluation to receive contact hours.

AAFP - Application for CME credit has been filed with the American Academy of Family Physicians.
Determination of credit is pending.



Registration

Advance registration for this symposium is now closed. You may still attend by registering in person at the registration desk starting at 7:00 AM on Saturday, October 23 at the symposium site, Jewish Hospital Rudd Heart & Lung Center, 201 Abraham Flexner Way, 16th Floor Conference Center Louisville, Kentucky 40202.
 


Refund Policy
Requests for cancellation must be submitted to chse@louisville.edu on or before Oct. 8, 2010. Requests received on or before  Oct. 8, 2010 will receive a full refund. No refund will be given for requests received after  Oct. 8, 2010.


Parking
Free parking is available to attendees in the parking garage adjacent to the Rudd Heart and Lung Center.


Driving Directions
For driving directions, go to http://www.mapquest.com


Brochure
Click here
for a copy of the course brochure, which contains information regarding speakers, topics,
etc. To download the file, right click on the link and select save as.

You must have Adobe Acrobat Reader to view the course brochure file. If you don't have it, it is a
free program that can be easily installed by clicking here. If you have installed Acrobat Reader and
the file still doesn't open, try right clicking on the brochure link and selecting "save target as"
to download the file to your computer.


Learning Objectives & Outcomes
1) Objective: Review the latest U.S. Preventive Services Task Force (USPSTF) recommendations.

Outcome: Utilize the latest USPSTF recommendations to decide when to start screening patients for breast cancer.

2) Objective: Identify mammograms and prediction models regarding node positive disease.

Outcome: Interpret mammograms and prediction models regarding node positive disease and decide whether auxiliary dissection on a patient should be omitted.

3) Objective: Describe post-mastectomy radiation therapy in immediate breast reconstruction verses post-mastectomy radiation therapy in later breast reconstruction.

Outcome: Advise patient’s on post-mastectomy radiation therapy in the setting of immediate reconstruction verses waiting on reconstruction and utilize appropriate methods to manage patients regardless of the choice.

4) Objective: Evaluate the pros and cons of accelerated partial breast irradiation (ABPI) as a standard of care for breast cancer patients.

Outcome: Include patients in the decision process by informing them about the indications and contraindications for accelerated partial breast irradiation (APBI).

5) Objective: Determine when patients should receive hormonal therapy, when hormonal therapy can be avoided and apply the guidelines for the measurement of ER-status.

Outcome: Follow the guidelines to measure ER-status to determine the indicators in patients for when hormonal therapy can be used and when it can be avoided.


Background/Needs Assessment
Breast cancer is the leading malignancy affecting women in the United States, with over 178,000 women being diagnosed each year. The management of patients with breast cancer is becoming increasingly complex, with multiple disciplines being involved in the patient's care. The need for communication between the disciplines and a broad understanding of multidisciplinary considerations is critical to optimize the management of breast cancer patients.

In addition, as advances in every field of breast cancer management are emerging at a rapid pace, it is imperative that practitioners stay current in their understanding of state-of-the-art care for their breast cancer patients. Controversies continue to exist regarding optimal care of breast cancer patients, especially in the current era of rapidly developing knowledge, and forums for open debate of these issues are needed.

Finally, the explosion of knowledge and information regarding the biology of breast cancer at the molecular level is significantly impacting the clinical management of patients, and there are issues in clinical practice that warrant investigation in the laboratory. The interaction between scientists and clinicians in a productive symposium allows not only for the development of fruitful collaborations but also the development of a broader understanding of breast cancer, from the bench to the bedside.

The purpose of the Louisville Breast Cancer Update is therefore to contribute to improved cancer discovery, detection and management through dissemination of knowledge and collaboration between scientists and clinicians. This is the only symposium of its kind in Kentucky.

The Louisville Breast Cancer Update began in 2004 as a regional meeting to disseminate and exchange knowledge regarding advances in the multidisciplinary management of breast cancer. The meeting has continued over the past six years, with attendance averaging 150 people per year. All aspects of the multidisciplinary management of breast cancer care are covered including imaging, surgical oncology, reconstruction, pathology, systemic chemotherapy, hormonal therapy, radiation oncology, and supportive care.

We have attracted nationally-renowned speakers including Gabriel Hortobagyi, David Page, Terry Mamounas, Frank Vicini, Kelly McMasters, Pat Whitworth, Vincente Valero, Charles Vogel, Banu Arun, Mitch Schnall, Elizabeth Rafferty and others. The meeting has been very well received, and evaluations from previous years have been very positive, with 98% of participants either agreeing or strongly agreeing that this should be an annual symposium.

Based on the evaluations of the previous years' symposia, there is a need to continue this annual symposium which has become an important source of information and education for health care providers caring for patients with breast cancer. The meeting continues to grow and gain recognition; in 2006, we were awarded a five-year R13 grant from the National Cancer Institute in support of this worthwhile educational event. However, this grant only provides partial support for this event, and sponsorship from community foundations and industry is critical.


Special Services
If you need special accommodations due to a disability, or for an alternative form of course materials, please contact us at chse@louisville.edu. Continuing Health Sciences Education fully complies with the legal requirements of the ADA and the rules and regulations thereof.


Accreditation
The University of Louisville School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Personal tools